InfuSystem Holdings, Inc. (INFU) is a publicly traded Healthcare sector company. As of September 17, 2026, INFU trades at $12.45 with a market cap of $247.97M and a P/E ratio of 29.74. INFU moved +0.24% today. Year to date, INFU is +48.75%; over the trailing twelve months it is +27.61%. Its 52-week range spans $4.61 to $12.97. Analyst consensus is moderatebuy with an average price target of $18.75. Rallies surfaces INFU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover INFU: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is moderatebuy. The average price target is $18.75.
| Metric | Value |
|---|---|
| Price | $12.45 |
| Market Cap | $247.97M |
| P/E Ratio | 29.74 |
| EPS | $0.42 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.97 |
| 52-Week Low | $4.61 |
| Volume | 136.72K |
| Avg Volume | 0 |
| Revenue (TTM) | $143.34M |
| Net Income | $8.54M |
| Gross Margin | 57.45% |
2 analysts cover INFU: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is moderatebuy. Average price target: $18.75.